Clinical Trials Browser

Phase 3 × Not yet recruiting × XELOX × Clear all

NCT07132463 2025-08-20

Neoadjuvant Chemoradiotherapy Followed by Chemotherapy With or Without Tislelizumab for Resectable Ultra-low Rectal Cancer: The RELIEVE-02 Study

Phase 3 Not yet recruiting

Gastrointestinal

Rectal Neoplasms

NCT07068516 2025-07-16

Perioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ Cancer

Phase 3 Not yet recruiting

Gastrointestinal

Gastric Cancer Stage